H2N(CH2)3N(tert-butoxycarbonyl)(CH2)4NH2

  Cat. No.:  DC67309   Featured
Chemical Structure
182576-24-5
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Cas No.: 182576-24-5
Chemical Name: Carbamic acid, (4-aminobutyl)(3-aminopropyl)-, 1,1-dimethylethyl ester
SMILES: NCCCCN(CCCN)C(=O)OC(C)(C)C
Formula: C12H27N3O2
M.Wt: 245.36168
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
Cat. No. Product name Field of application
DC67313 6-Oxohexyl 2-hexyldecanoate
DC67312 1-Propanethiol, 3-(diMethylaMino)-, hydrochloride
DC67311 1-Propanaminium, 2,3-dihydroxy-N,N,N-trimethyl-, chloride (1:1), (2R)-
DC67310 1,4-Piperazinediethylamine
DC67309 H2N(CH2)3N(tert-butoxycarbonyl)(CH2)4NH2
DC67308 CbzNH-PEG1-Br
DC67307 1-Piperazineethanamine, N-(phenylmethyl)-
DC67306 1-Propanethiol, 3-(dimethylamino)-, 4-methylbenzenesulfonate (1:1)
DC60798 6-[1-(Hexyloxy)ethoxy]hexanal(MK16 tail) 6-[1-(Hexyloxy)ethoxy]hexanal is the tail fragement for MK16.MK16 is a novel blood-brain barrier (BBB)-crossing lipid nanoparticle (BLNP) platform developed for efficient mRNA delivery to the central nervous system (CNS).
DC67297 SM6.1 (αvβ6 ligand) SM-6.1 is a small molecule delivery vehicle developed by Arrowhead, targeting αvβ6, which selectively delivers therapeutic siRNA to lung epithelial cells and mediates durable gene silencing post-inhalation.
X